Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Windlas Biotech Ltd

NSE: WINDLAS · BSE: 543329 · Pharmaceuticals & Biotechnology · 33 announcements

Share price
₹1,029.00
Market cap
₹2,160 Cr
Revenue (annual)
₹904.1 Cr
Net profit (annual)
₹66.44 Cr
P/E (TTM)
32.5×Sector 47.4×
Promoter holding
63.31%+1.41% QoQ
FII holding
2.04%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

16:24 IST BSE
Credit Rating

Windlas Biotech Credit Rating

ICRA reaffirmed Windlas Biotech's long-term rating at [ICRA]A+(Stable) and upgraded short-term facilities to [ICRA]A1+. The rated amount totals ₹84.9 Crore.

Value
₹84.90 Cr